Skip to content

Pregnolia System Intra-observer Variability

Intra-observer Variability in the Assessment of Cervical Stiffness With the Pregnolia System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05200117
Enrollment
26
Registered
2022-01-20
Start date
2022-01-12
Completion date
2023-12-17
Last updated
2024-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Stiffness, Cervix; Pregnancy

Keywords

Cervical Stiffness, Intra-Observer Variability, Pregnolia System, Cervical Stiffness Index, CSI, Stiffness measurement

Brief summary

The Pregnolia System is a CE-marked medical device assessing the mechanical stiffness of cervical tissue in women. The Pregnolia Probe has been engineered to minimize the influence of differences in handling and technique by the user. This project aims to study intra-observer variability of the Pregnolia System in pregnant women in the clinical setting. Furthermore, a same day repeated measurement serves to investigate the time period needed to recover the pre-measurement stiffness state due to viscoelasticity of the cervical tissue.

Interventions

The cervical stiffness is measured with the Pregnolia System three times over a two-day period.

Sponsors

Pregnolia AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Informed Consent signed by the subject * Pregnant woman * Singleton pregnancy * 18 years or older * Nulliparous cohort: nulliparous pregnant woman * Multiparous cohort: multiparous pregnant woman

Exclusion criteria

* Lack of informed consent * Placenta praevia totalis with haemorrhage (irrespective of severity) * Severe vaginal bleeding * Rupture of membranes before 34 weeks (to be excluded with pH test) * Visible tissue scarring at 12 o'clock position on cervix * Light bleeding (if the bleeding can be stopped, it is no longer an exclusion criterion) * Cervical dilation ≥ 3 cm * Cerclage or pessary in place

Design outcomes

Primary

MeasureTime frameDescription
Cervical Stiffness IndexMeasurements between 14+0 and 41+6 weeks gestational weeksCervical Stiffness Index (CSI, in mbar) measured repeatedly after 2 to 4 hours and approximately 24 hours at three different locations on the uterine cervix.

Secondary

MeasureTime frameDescription
Cervical Stiffness Index (CSI, in mbar)Measurements between 14+0 and 41+6 weeks gestational weeks
Elapsed time betweenMeasurements between 14+0 and 41+6 weeks gestational weeksThe elapsed time between when the subject got out of bed until the measurements were taken
Device-related adverse eventsMeasurements between 14+0 and 41+6 weeks gestational weeksDevice-related adverse events (incidence, severity, and seriousness)

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026